FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Lamisil Tablets
Status: Discontinuation
»Therapeutic Categories:

Novartis (New 11/15/2017)

Company Contact Information:
888-669-6682

Presentation Posting Date Related Information
Lamisil Tablets 250mg Bottles of 30 (NDC 0078-0179-15) 11/15/2017 Novartis Pharmaceuticals has made a business decision to permanently discontinue the product Lamisil Tablets 250mg. Lamisil Tablets 250mg will be available until approximately the end of April 2018.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English